Author

Andrea Garrett

Wesley Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Aimee L. DavidsoniD· 1 shared Ann‐Marie PatchiD· 1 shared Asmerom Tesfamariam SengaliD· 1 shared Claire M. DaviesiD· 1 shared Deborah S. SmithiD· 1 shared Felicity NewelliD· 1 shared James NickliniD· 1 shared John V. PearsoniD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Aimee L. DavidsonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genomic analysis of patient-derived xenograft models reveals intra-tumor heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib

Vanessa Bonazzi, Olga Kondrashova, Deborah S. Smith, Kátia Nones, Asmerom Tesfamariam Sengal, Robert J. Ju, Leisl Packer, Lambros T. Koufariotis, Stephen H. Kazakoff, Aimee L. Davidson, Priya Ramarao-Milne, Vanessa Lakis, Felicity Newell, Rebecca Rogers, Claire M. Davies, , Pamela M. Pollock

The paper develops endometrial cancer PDX models that capture tumor heterogeneity and predict response to talazoparib.

Genome Medicine · Jan 10, 2022Peer-reviewedGenomics